Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

California Cannabis Testing Highlights the Importance of Quality Control and Safe Processes -- CFN Media


Posted on: 14 Aug 18

SEATTLE, WA, Aug. 14, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Rubicon Organics™, a private company soon to go public with the intent to demonstrate that certified organic products, properly tested and labeled, can lead the way toward creating consumer confidence in the nascent legal cannabis industry. As cannabis cultivation comes out of the basements and closets into the fully regulated light of day, Rubicon believes that adhering to the most strict quality and health standards is essential to building brands that consumers can trust with their well-being.

According to statistics provided by California’s Bureau of Cannabis Control, 20% of all cannabis products analyzed by August 6, 2108 received a failed certificate of analysis. The most common reason was inaccurate labeling, for instance misrepresenting the percentage of CBD in a product. Together, the presence of disallowed pesticides, solvents, and microbials account for 30% of the failed certificates. Clearly, cultivators and manufacturers are having a difficult time creating safe and trusted products for the world’s largest legal cannabis market, and the problems are not limited to California. Similar situations have occurred in Canada with Licensed Producers.

Please click here to download Rubicon’s corporate presentation and to receive an email alert before the company goes public.

Dirty Pot

Smaller sample studies from earlier in 2018 present even more alarming statistics than those noted above. Steep Hill Labs collected samples from 15 dispensaries in Southern California and found 93% of samples tested positive for pesticides. Then Steep Hill followed up with a study pointing to the cloning process, and the growth media used to promote root growth, as possible culprits for the widespread positive tests. 

With the scientific understanding of cannabis just now advancing due to relaxed regulations, following years of restrictions, it is clearer what is not known with certainty than what is. Agricultural technology research is turning its focus to cannabis, and ultimately cultivators will benefit from genetic selection and research-driven advancements such as safe, cannabis-specific pesticides. For now, many growers are going with what they know, and when faced with widespread crop loss may bend the new rules some to protect their investment.

The Rubicon Organics™ Solution

The founders of Rubicon Organics were in on the ground floor of the world’s first certified organic producer, Whistler Medical Marijuana Corporation. After leaving that successful venture, Rubicon’s CEO and CSO started experimenting with organic greenhouse cultivation. From improving on the classic Dutch Venlo greenhouse design, to creating their own proprietary soil mixes and growth media, the two perfected the art and the science of growing certified organic cannabis using greenhouse technology.

Please click here to download Rubicon’s corporate presentation and to receive an email alert before the company goes public.

The result is Rubicon Organics™, on the verge of becoming Canada’s third certified organic licensed producer. Its 125,000 square foot Delta, BC greenhouse facility is in the detailed review stage of the ACMPR permitting process. The company also owns a 40,000 sf state-of-the art and custom designed greenhouse in Washington state that is currently leased to a licensed producer there, and has an off-take agreement with a 120,000 sf outdoor operation in California. Rubicon owns two brands of cannabis products, with the 1964 Supply Co.™ brand distributed in California and the Doctor & Crook Co.™ brand distributed in Washington through a state-licensed processor.

See a short video of Rubicon’s Delta BC facility here: https://youtu.be/M3pjFniutRg

Cultivating large amounts of consistent, high quality cannabis at a low cost is a difficult proposition. Rubicon believes it can produce such crops, certified organic, at a cost of $.50/gram once facilities are running at full production levels. The certified organic distinction allows the company to charge a premium for its products, translating to healthier margins than non-organic producers operating with similar production costs.

In seeking to build a family of cannabis products that consumers can trust implicitly, Rubicon is betting on organics as a seal of quality, health, and safety. Consumer trends toward organic products reinforce the soundness of the strategy, as does the current lack of certified organic cannabis. Utilizing the company’s own proprietary growing supplies and system, based on years of research and experimentation, should allow Rubicon to limit the variables and inputs that can create uncertainty in the growing environment. Stay tuned, as Rubicon Organics™ plans on going public soon and anticipates plenty of major developments in the coming months.

Please click here to download Rubicon’s corporate presentation and to receive an email alert before the company goes public.

Please follow the link to read the full article: http://www.cannabisfn.com/california-cannabis-testing-highlights-importance-quality-control-safe-processes/

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

CONTACT: CFN Media Frank Lane 206-369-7050 flane@cannabisfn.comGlobeNewswire
globenewswire.com

Last updated on: 14/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.